DiscoverAcademicCME Podcast
AcademicCME Podcast
Claim Ownership

AcademicCME Podcast

Author: Patrick Hayes

Subscribed: 0Played: 2
Share
© Patrick Hayes

Description

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice
48 Episodes
Reverse
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

2025-08-2152:12

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-1/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.
Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

2025-07-3125:09

This activity was supported by an educational grant from EMD Serono. Please go to ⁠⁠academiccme.com/McDonaldPod and complete the evaluation to receive your CE/CME Credit. Credit is available through October 23, 2025.
Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

2025-07-1840:12

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.
ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

2025-07-1649:24

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to ⁠http://academiccme.com/ATTRPod and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

2025-03-1736:38

This activity was supported by an educational grant from Insmed. Please go to academiccme.com/EPCNCFBE and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

2025-03-1738:09

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to  ⁠academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

2024-12-0329:06

This activity was supported by an educational grant from Mylan Specialty L.P., a Viatris Company. Please go to  ⁠academiccme.com/front-matter/copd-podcast/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 2, 2025.
DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

2024-11-2126:46

This activity was supported by an educational grant from Travere Therapeutics. Please go to ⁠https://academiccme.com/CKDCE3/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through November 21, 2025.
PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

2024-11-0532:11

This activity was supported by an educational grant from Ipsen. Please go to  ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
Clinical Trial Data Review for PBC Therapeutics

Clinical Trial Data Review for PBC Therapeutics

2024-10-1731:09

This activity was supported by an educational grant from Ipsen. Please go to  ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

2024-10-1637:57

This activity was supported by an educational grant from Ipsen. Please go to  academiccme.com/PBCCME⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

2024-08-0601:11:30

This activity was supported by an educational grant from argenx US Inc. Please go to ⁠⁠academiccme.com/MGInfusionsCE⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 5, 2025.
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

2024-06-1924:22

This activity was supported by an educational grant from Travere Therapeutics. Please go to https://academiccme.com/CKDCE1/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
VTE and Anticoagulation - Guideline Updates for 2024

VTE and Anticoagulation - Guideline Updates for 2024

2024-04-2528:29

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE4/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

2024-03-2629:35

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE3/ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 24, 2025.
Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

2024-01-1032:23

This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE/ and complete the evaluation to receive your CE/CME Credit.
Part 1: Advances in Patient-Actuated Treatment for PSVT

Part 1: Advances in Patient-Actuated Treatment for PSVT

2023-08-1628:10

This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
Part 2: Advances in Patient-Actuated Treatment for PSVT

Part 2: Advances in Patient-Actuated Treatment for PSVT

2023-08-1635:06

This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

2023-01-0901:01:02

Please go to academiccme.com/ovariancancer/ and complete the evaluation to receive your CE/CME Credit.
Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies

Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies

2023-01-0331:19

Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
loading
Comments 
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States